A citation-based method for searching scientific literature

Carlos Cepeda, Michael S Levine. Neuroscientist 2022
Times Cited: 12







List of co-cited articles
97 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
41

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
41

Cortical and Striatal Circuits in Huntington's Disease.
Sonja Blumenstock, Irina Dudanova. Front Neurosci 2020
22
33

Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
629
33

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
203
33

The Biology of Huntingtin.
Frédéric Saudou, Sandrine Humbert. Neuron 2016
405
33

The Neuropathology of Huntington's Disease.
Henry J Waldvogel, Eric H Kim, Lynette J Tippett, Jean-Paul G Vonsattel, Richard L M Faull. Curr Top Behav Neurosci 2015
86
25

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
446
25

Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.
H Heinsen, U Rüb, D Gangnus, G Jungkunz, M Bauer, G Ulmar, B Bethke, M Schüler, F Böcker, W Eisenmenger,[...]. Acta Neuropathol 1996
68
25

Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.
Ina Han, YiMei You, Jeffrey H Kordower, Scott T Brady, Gerardo A Morfini. J Neurochem 2010
94
25

Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.
Nan Wang, Michelle Gray, Xiao-Hong Lu, Jeffrey P Cantle, Sandra M Holley, Erin Greiner, Xiaofeng Gu, Dyna Shirasaki, Carlos Cepeda, Yuqing Li,[...]. Nat Med 2014
137
25

Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Anton Reiner, Evan Shelby, Hongbing Wang, Zena Demarch, Yunping Deng, Natalie Hart Guley, Virginia Hogg, Richard Roxburgh, Lynette J Tippett, Henry J Waldvogel,[...]. Mov Disord 2013
61
25

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
97
25

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
261
25

Earliest functional declines in Huntington disease.
Leigh J Beglinger, Justin J F O'Rourke, Chiachi Wang, Douglas R Langbehn, Kevin Duff, Jane S Paulsen. Psychiatry Res 2010
89
25

Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
121
25

Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release.
He Li, Travis Wyman, Zhao-Xue Yu, Shi-Hua Li, Xiao-Jiang Li. Hum Mol Genet 2003
102
25

Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism.
Niels H Skotte, Jens V Andersen, Alberto Santos, Blanca I Aldana, Cecilie W Willert, Anne Nørremølle, Helle S Waagepetersen, Michael L Nielsen. Cell Rep 2018
49
25


The Neuropsychology of Huntington's Disease.
Julie S Snowden. Arch Clin Neuropsychol 2017
51
16


Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms.
Carlos Cepeda, Damian M Cummings, Véronique M André, Sandra M Holley, Michael S Levine. ASN Neuro 2010
61
16

Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.
Sarah J Tabrizi, Rhia Ghosh, Blair R Leavitt. Neuron 2019
88
16

Cholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum.
Michael J Higley, Aryn H Gittis, Ian A Oldenburg, Nina Balthasar, Rebecca P Seal, Robert H Edwards, Bradford B Lowell, Anatol C Kreitzer, Bernardo L Sabatini. PLoS One 2011
125
16

Differential inputs to striatal cholinergic and parvalbumin interneurons imply functional distinctions.
Jason R Klug, Max D Engelhardt, Cara N Cadman, Hao Li, Jared B Smith, Sarah Ayala, Elora W Williams, Hilary Hoffman, Xin Jin. Elife 2018
43
16

Heterogeneity and Diversity of Striatal GABAergic Interneurons: Update 2018.
James M Tepper, Tibor Koós, Osvaldo Ibanez-Sandoval, Fatuel Tecuapetla, Thomas W Faust, Maxime Assous. Front Neuroanat 2018
81
16

Concurrent activation of striatal direct and indirect pathways during action initiation.
Guohong Cui, Sang Beom Jun, Xin Jin, Michael D Pham, Steven S Vogel, David M Lovinger, Rui M Costa. Nature 2013
671
16

Evidence for specific cognitive deficits in preclinical Huntington's disease.
A D Lawrence, J R Hodges, A E Rosser, A Kershaw, C ffrench-Constant, D C Rubinsztein, T W Robbins, B J Sahakian. Brain 1998
308
16


Striatal microcircuitry and movement disorders.
Aryn H Gittis, Anatol C Kreitzer. Trends Neurosci 2012
121
16

Heterogeneity and diversity of striatal GABAergic interneurons.
James M Tepper, Fatuel Tecuapetla, Tibor Koós, Osvaldo Ibáñez-Sandoval. Front Neuroanat 2010
277
16

Re-emergence of striatal cholinergic interneurons in movement disorders.
Antonio Pisani, Giorgio Bernardi, Jun Ding, D James Surmeier. Trends Neurosci 2007
309
16


The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
16

Striatal interneurones: chemical, physiological and morphological characterization.
Y Kawaguchi, C J Wilson, S J Augood, P C Emson. Trends Neurosci 1995
920
16


Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington's Disease.
Sandra M Holley, Prasad R Joshi, Anna Parievsky, Laurie Galvan, Jane Y Chen, Yvette E Fisher, My N Huynh, Carlos Cepeda, Michael S Levine. eNeuro 2015
36
16

GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease.
N Lozovaya, S Eftekhari, R Cloarec, L A Gouty-Colomer, A Dufour, B Riffault, M Billon-Grand, A Pons-Bennaceur, N Oumar, N Burnashev,[...]. Nat Commun 2018
38
16

Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3a(EGFP) Mouse.
A B Muñoz-Manchado, C Foldi, S Szydlowski, L Sjulson, M Farries, C Wilson, G Silberberg, J Hjerling-Leffler. Cereb Cortex 2016
43
16

Cholinergic neuronal defect without cell loss in Huntington's disease.
Ruben Smith, Hinfan Chung, Sara Rundquist, Marion L C Maat-Schieman, Lesley Colgan, Elisabet Englund, Yong-Jian Liu, Raymund A C Roos, Richard L M Faull, Patrik Brundin,[...]. Hum Mol Genet 2006
101
16

Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Joshua L Plotkin, Michelle Day, Jayms D Peterson, Zhong Xie, Geraldine J Kress, Igor Rafalovich, Jyothisri Kondapalli, Tracy S Gertler, Marc Flajolet, Paul Greengard,[...]. Neuron 2014
122
16

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
16


Disrupted striatal neuron inputs and outputs in Huntington's disease.
Anton Reiner, Yun-Ping Deng. CNS Neurosci Ther 2018
42
16

Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Tara E Wood, Joshua Barry, Zhenquin Yang, Carlos Cepeda, Michael S Levine, Michelle Gray. Hum Mol Genet 2019
45
16

Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
16

Cortical circuit alterations precede motor impairments in Huntington's disease mice.
Johanna Burgold, Elena Katharina Schulz-Trieglaff, Kerstin Voelkl, Sara Gutiérrez-Ángel, Jakob Maximilian Bader, Fabian Hosp, Matthias Mann, Thomas Arzberger, Rüdiger Klein, Sabine Liebscher,[...]. Sci Rep 2019
21
16

Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease.
H Heinsen, U Rüb, M Bauer, G Ulmar, B Bethke, M Schüler, F Böcker, W Eisenmenger, M Götz, H Korr,[...]. Acta Neuropathol 1999
71
16

Detection of Huntington's disease decades before diagnosis: the Predict-HD study.
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger,[...]. J Neurol Neurosurg Psychiatry 2008
552
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.